Brexit Will Cost U.K. Research Funding, Report Indicates

Clinical medicine and biosciences are among the UK disciplines that receive the most EU funding.

Written byAshley P. Taylor
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, Håkan DahlströmA report out today (May 24) lays out how much of the U.K.’s research funding came from the European Union in 2014/2015—and how much funding Britain stands to lose when Brexit goes into effect. Life sciences could be hard-hit after the U.K. leaves the European Union, the report suggests.

Of all academic areas in the U.K., archaeology receives the greatest proportion of its funds (38 percent) from the E.U., followed by classics and information technology.

“In archaeology we’re more worried than most. There’s no doubt that British-based archaeologists have been extraordinarily successful in these [EU grant] competitions,” University of York archaeologist Matthew Collins told BuzzFeed News. “Realistically, if you’re going to have that kind of drop in funding, what kind of impact is that going to have on British archaeology?”

Clinical medicine received the greatest amount of EU funds (£120 million), followed by biosciences, physics, and chemistry, according to a release from the Royal Society, which, along with the U.K.’s other three national academies, commissioned the report from the Technopolis Group.

“Given the high ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies